ANDREA ANDERSON: Open Payments
NPI 1639823198 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 14 payments from 11 companies in 2025. Trend: 2023 $149 · 2024 $0 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $30 |
| Eisai Inc. | 1 | $28 |
| Corcept Therapeutics | 1 | $25 |
| Seqirus USA Inc | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, Leqembi, Korlym, Fluad, Ozempic, Symbravo.
Industry payments across TX — which companies pay providers there.
